<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03157323</url>
  </required_header>
  <id_info>
    <org_study_id>AAAQ9790</org_study_id>
    <nct_id>NCT03157323</nct_id>
  </id_info>
  <brief_title>Low GI Diet in Children and Adolescents With ALL</brief_title>
  <official_title>Implementing a Low Glycemic Diet in Children and Adolescents Undergoing Treatment for Acute Lymphoblastic Leukemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Cancer Society, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gabrielle's Angel Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to determine the feasibility of a 6-month low glycemic dietary intervention in&#xD;
      children and adolescents undergoing treatment for acute lymphoblastic leukemia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy with survival&#xD;
      exceeding 90%. However, treatment-related toxicity remains a clinical challenge during and&#xD;
      after treatment. Evidence-based, nutritional interventions may minimize the development of&#xD;
      nutrition-related toxicities, such as bone morbidities, hypertriglyceridemia, and obesity. To&#xD;
      date, no effective interventions are available to prevent nutrition-related morbidities in&#xD;
      children with ALL. Clinical studies evaluating the glycemic indices in other pediatric&#xD;
      conditions have been encouraging. It is plausible that reducing the glycemic indices of diets&#xD;
      during cancer treatment may have a profound clinical effect in this vulnerable pediatric&#xD;
      population. Prior to the design and implementation of randomized, controlled trials,&#xD;
      epidemiological data describing the Glycemic Index (GI) and Glycemic Load (GL) and the&#xD;
      association with clinically important outcomes is needed. Additionally, the feasibility of a&#xD;
      dietary intervention must also be explored within the setting of pediatric cancer. This study&#xD;
      aims to determine the feasibility, measured by compliance to a low-GI diet, of a 6-month low&#xD;
      glycemic dietary intervention in children and adolescents undergoing treatment for ALL. The&#xD;
      proposed work will be used for the design and implementation of a multi-center nutritional&#xD;
      intervention aimed at improving dietary intake during treatment and its effect on clinically&#xD;
      important outcomes. Importantly, the information will be used to drive the formation of&#xD;
      evidence-based nutritional guidelines for children with cancer, which will expand into the&#xD;
      emerging field of individualized medicine for patients with cancer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of a 6-month low glycemic dietary intervention in children and adolescents undergoing treatment for ALL.</measure>
    <time_frame>6 months</time_frame>
    <description>Feasibility will be measured by compliance to a low glycemic index diet, which will be measured via 24 dietary recall, using the Automated Self-Administered 24-Hour Dietary Assessment Tool. A dietary recall will be taken at 7 timepoints from diagnosis to end of treatment; each recall will be defined categorically as high compliance (GI score &lt;55), moderate compliance (GI score 56-69) and low compliance (GI score &gt;70). Change in glycemic index score will show compliance.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Acute Lymphoblastic Leukemia, Pediatric</condition>
  <condition>Obesity, Pediatric</condition>
  <arm_group>
    <arm_group_label>Low Glycemic Index Diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Following a low glycemic index diet verses a standard american diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low Glycemic Index Diet</intervention_name>
    <description>The nutritional intervention is theory-based and will provide nutritional education and counseling to children and their families. Nutritional counseling will be provided by the institutional designate and will focus on increasing patients' understanding of the benefits of a low GI diet, increase knowledge of low GI diet, overcoming barriers, and establishing expectations of the diet.</description>
    <arm_group_label>Low Glycemic Index Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of Acute Lymphoblastic Leukemia (B-Cell, T-Cell, or Mixed Phenotype)&#xD;
&#xD;
          -  Within 3 days of starting the induction phase of treatment for Acute Lymphoblastic&#xD;
             Leukemia&#xD;
&#xD;
          -  Proficient in English or Spanish&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of relapsed Acute Lymphoblastic Leukemia&#xD;
&#xD;
          -  Not meeting all of the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena Ladas, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michelle Walters, MS, RD</last_name>
    <phone>6463172080</phone>
    <email>mw3328@cumc.columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elena Ladas, PhD</last_name>
    <phone>2123057835</phone>
    <email>ejd14@cumc.columbia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Connecticut Children's Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Orsey, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's National Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacobs Shana, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Roswell Park Cancer Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Kelly, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Walters, MS, RD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracey Jubelirer, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 6, 2017</study_first_submitted>
  <study_first_submitted_qc>May 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2017</study_first_posted>
  <last_update_submitted>June 10, 2019</last_update_submitted>
  <last_update_submitted_qc>June 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Elena Ladas</investigator_full_name>
    <investigator_title>Assistant Professor of Nutrition in Pediatrics and in the Institute of Human Nutrition</investigator_title>
  </responsible_party>
  <keyword>Glycemic Index</keyword>
  <keyword>Acute Lymphoblastic Leukemia</keyword>
  <keyword>Dietary Change</keyword>
  <keyword>Pediatric Oncology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

